The staining and intensity data revealed that the expression levels of MCM2 were strikingly higher and stronger in TGCT, CESC, SKCM, DLBC, OV, COAD, BRCA and PAAD tissues compared to normal tissues (Figure 2B). The gene discussed is MCM2; the disease is pancreatic adenocarcinoma.